Nothing new for me. A little disappointing. Most of this we knew from the 4C announced 30/7. The operating loss was disclosed. The difference now being depreciation and write downs. Centres remain over 90 so it may have been say 92 and now 96 or so as they pick up about 1 a week but it would have been nice to be specific...also no number of patients implanted disclosed this time. Will just have to see what the September 4C brings. The bulk of costs seem to relate to setting up the sales teams and infrastructure around them. Not sure if they are one offs or recurring costs.
One thing different is HSV2 interim data looks to be due by 30 June 16 instead of end of 2015. Strange how the morning announcement said end of 2015. I think a few on here suggested that they may be delayed.
Otherwise I'm positive revenues should show a larger increase coming quarter as it takes about 6 to 12 months for a centre to come fully online.Guess I'll hold for a couple more months.
AHZ Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
